RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)

CUSIP: 75382E109

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-141,953
Put/Call ratio
70%
SEC-reported price per share
$3.05
Number of holders
100
Value change
-$20,514,565
Number of buys
51
Open additional details 1 more signal available
Number of sells
71
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,725,634

Security key

75382E109

Report period

Q2 2024

Institutions

100

Top holders

10

Ownership snapshot

Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Peter Svennilson
Disclosed value leader
Column Group LLC
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $24,071,977 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Column Group LLC has the largest disclosed position value at $24.07M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Column Group LLC's linked filing trail.
Disclosed position value Top 5
Peter Svennilson $56.8K
Column Group LLC $24.07M
VANGUARD GROUP INC $22.39M
BlackRock Finance, Inc. $22.2M
PRICE T ROWE ASSOCIATES INC /MD/ $18.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Peter Svennilson
3/4/5
Director, 10%+ Owner
—
denominator unverified
$56,850
7,500 shares
— 28 May 2021
Column Group LLC
13F
Company
13F
—
denominator unverified
$24,071,977
2,680,621 shares
— 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$22,385,792
2,492,850 shares
— 31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$22,199,933
2,472,153 shares
— 31 Mar 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$18,214,000
2,028,166 shares
— 31 Mar 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$17,109,900
1,905,334 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
100
Shares
31,808,667
Rows available
100
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q4 2025 Across Filers

Q4 2025 holders
3
Q2 2024 holders
100
Holder diff
97
Investor Q4 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q4 2025 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .